Published in Cardiovascular Business Week, February 5th, 2008
"The potential mechanisms for these CV effects are also presented. Although the studies evaluating the CV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.